Biotechnology Organizations In Action

This volume analyzes the dynamics and interactive processes among the players (individuals, institutions, and organizations/firms) that have constituted and legitimized the development of the biotechnology industries. The unit of analysis is small entrepreneurial firms developing biotechnological products and processes. What types of strategies are small entrepreneurs pursuing in order to create markets for their new products and processes, and how have specific strategies emerged? The primary interest is the network process through which the technological field and the development of institutions and routines evolve and co-evolve. The theoretical contribution of the book is its focus on the development of the concept of networks. From being regarded as a relative static concept the book transforms the concept into a dynamic concept of networking. The dynamic view on the creation and development of new technologies through network formations is linked to the concept of strategy that is used throughout the book. Hence the strategies are developed along with the creation of technological knowledge, and it is hoped that the diffusion of this specific knowledge will bring new actors into the technological arena or community. This book will be useful to the academic community, those studying the formation of networks, strategic management, organizational behavior, and management of technology, as well as business observers with a specific interest in the evolution of the biotechnology industry.

Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.

The same technologies that fuel scientific advances also pose potential risks-that the knowledge, tools, and techniques gained through legitimate biotechnology research could be misused to create biological weapons or for bioterrorism. This is often called the dual use dilemma of the life sciences. Yet even research with the greatest potential for misuse may offer significant benefits. Determining how to constrain the danger without harming essential scientific research is critical for national security as well as prosperity and well-being. This book discusses a 2007 survey of American Association for the Advancement of Science (AAAS) members in the life sciences about their knowledge of dual use issues and attitudes about their responsibilities to help mitigate the risks of misuse of their research. Overall, the results suggest that there may be considerable support for approaches to oversight that rely on measures that are developed and implemented by the scientific community itself. The responses also suggest that there is a need to clarify the scope of research activities of concern and to provide guidance about what actions scientists can take to reduce the risk that their research will be misused by those with malicious intent.

This book brings together a comprehensive collection of empirically-grounded and theoretically-informed research projects from studies of organizational practice which explore a number of technological changes.

In this authoritative exploration of contemporary organisations and the ways they mirror their environment, Howard Aldrich and Martin Ruef chart the development of organisational forms, as well as assessing the impact on these of external innovations.

Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.

Networks & Organizations debunks the myth that we are in the midst of an unprecedented era of change & refocuses attention on the timeless problem of management--mobilizing individual & collective action. The authors take a fresh look at what actually happens in organizations & reveal how rhetoric & the search for identity--not structure, systems, & strategies that characterize the design perspective of organizations--are the real motivators of action in organizations. They then offer an alternative view in which robust action (not equilibrium), fit, & alignment should serve as a positive guide for managerial action.